1 Department of Radiology, Massachusetts General Hospital, 55 Fruit St, WAC 240, Boston, MA 02114.
2 Department of Surgery, Massachusetts General Hospital, Boston, MA.
AJR Am J Roentgenol. 2018 Oct;211(4):940-945. doi: 10.2214/AJR.18.19637. Epub 2018 Aug 7.
OBJECTIVE: The purpose of this study is to evaluate the feasibility and effectiveness of a nonradioactive magnetic marker wireless localization technique. MATERIALS AND METHODS: A retrospective review was performed of consecutive patients who underwent image-guided needle localization with nonradioactive magnetic markers and subsequent surgical excision from March to August 2017. Indications for marker placement, lesion type, imaging guidance used for marker placement, postprocedure mammographic imaging and reports, surgical reports, and surgical margin status were reviewed. RESULTS: A total of 188 patients (mean age, 59 years; range, 22-89 years) underwent image-guided localization with 213 magnetic markers and subsequent surgical excision. The indications for marker placement included invasive carcinoma (96 markers [45.1%]), ductal carcinoma in situ (41 markers [19.2%]), and high-risk lesions (71 markers [33.3%]). Localization markers were most commonly placed for masses (96 markers [45.1%]) and were deployed under mammographic guidance (160 markers [75.1%]) or sonographic guidance (53 markers [24.9%]). Technical success, which was defined as placement of the magnetic marker within 1 cm of the target, was achieved for 206 of 213 markers (96.7%). All 213 markers were successfully retrieved at surgery. Of 137 cases of in situ or invasive carcinoma, 30 (21.9%) had tumor-positive or close surgical margins that required reexcision. No major or minor complications were observed during marker placement, intraoperatively, or postoperatively. CONCLUSION: Image-guided needle localization with magnetic markers is a safe, feasible, and effective method for localizing breast lesions. Magnetic marker localization has the potential to replace conventional wire needle localization and radioactive seed needle localization for lesions that require surgical excision.
目的:本研究旨在评估一种非放射性磁性标记物无线定位技术的可行性和有效性。
材料与方法:对 2017 年 3 月至 8 月期间连续接受非放射性磁性标记物引导下的经皮针定位活检并随后行手术切除的患者进行回顾性分析。评估内容包括:标记物放置的适应证、病变类型、用于标记物放置的影像学引导方法、术后乳腺 X 线摄影检查和报告、手术报告以及手术切缘状态。
结果:共 188 例患者(平均年龄 59 岁,范围 22-89 岁)接受了 213 个磁性标记物的引导下定位活检,并随后进行了手术切除。标记物放置的适应证包括浸润性癌(96 个标记物[45.1%])、导管原位癌(41 个标记物[19.2%])和高危病变(71 个标记物[33.3%])。定位标记物最常用于定位肿块(96 个标记物[45.1%]),并在乳腺 X 线摄影引导(160 个标记物[75.1%])或超声引导(53 个标记物[24.9%])下放置。技术成功定义为将磁性标记物放置在目标 1cm 范围内,213 个标记物中有 206 个(96.7%)达到了该标准。所有 213 个标记物均在手术中成功取出。在 137 例原位癌或浸润性癌患者中,30 例(21.9%)肿瘤阳性或切缘接近,需要再次切除。在标记物放置、术中或术后均未观察到主要或次要并发症。
结论:经皮针引导下的磁性标记物定位是一种安全、可行且有效的定位乳腺病变的方法。与传统的金属丝针定位和放射性粒子针定位相比,磁性标记物定位具有为需要手术切除的病变定位的潜力。
AJR Am J Roentgenol. 2018-8-7
AJR Am J Roentgenol. 2021-9
AJR Am J Roentgenol. 2019-1-23
AJR Am J Roentgenol. 2018-2-15
AJR Am J Roentgenol. 2019-6-5
Cancers (Basel). 2024-1-29
Indian J Surg Oncol. 2022-9
Breast Care (Basel). 2021-8